Chris Neary is the founder of NanoCellect Biomedical. NanoCellect Biomedical has raised $86M in total funding. Latest round: Series AA.
Chris Neary is the CEO of NanoCellect Biomedical, a San Diego-based biotech company specializing in microfluidic cell sorting and imaging solutions. He has led the company through multiple funding rounds, including a $35 million Series C and D combined round in 2021 and a $19.4 million Series AA round in June 2023. Neary oversees product development and growth strategies for NanoCellect's VERLO cell imaging platform and cell sorting technologies.
Full founder directory · Investor directory · Company funding database · Fundraising library